Three Key Observations from Efforts to Restore 340B Discounts in the States
By Ted Slafsky
After six months of heated battles in the states to restore access to 340B drug discounts in the contract pharmacy setting, it’s a good time to reflect on providers’ progress and setbacks.
Twenty-five states, an unprecedented number, have introduced bills to require drug manufacturers to provide 340B discounts to covered entities that contract with chain, community or other types of pharmacies. Read More >
